Menu
Back to Journals » OncoTargets and Therapy » Volume 15
MicroRNA-217 Acts as a Tumor Suppressor and Correlates with the Chemoresistance of Cervical Carcinoma to Cisplatin [Expression of Concern]
Received 2 August 2022
Accepted for publication 2 August 2022
Published 4 August 2022 Volume 2022:15 Pages 841—842
Yin Z, Ren W. Onco Targets Ther. 2019;12:759–771.
The Editor and Publisher of OncoTargets and Therapy wish to issue an Expression of Concern for the published article.
Following publication, concerns were raised about the scientific integrity of the articles content. We reached out to the authors requesting they supply information that would confirm the integrity of the data. However, the authors did not provide the requested files and could not satisfy our requirements to confirm the authenticity of some types of data.
Therefore, as we continue to work through the issues raised, we advise readers to interpret the information presented in the article with due caution.
The authors have been notified about this Expression of Concern.
© 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.